Epidemiology and current treatment of urogenital tuberculosis.
In West Germany the incidence of new cases of genitourinary tuberculosis has continued to decline just as the trend of the tuberculosis situation decreased in the development countries, which is certainly due to modern chemotherapy and effective hygienic health care. Genitourinary manifestation also follows the consistently steady decline of tuberculosis. Most patients are in the age group 31 to 55 years, and the average rate of patients from the Third World is high. The actual epidemiological data are presented. The modalities of modern treatment are reported, especially modern short course chemotherapy, toxicity of modern antituberculous drugs, the problems of a inpatient or outpatient treatment and the complication of HIV infection and tuberculosis are discussed.